BIOMARIN PHARMA earnings per share and revenue

BM8 earnings per share for the last quarter are 0.41 CHF whereas the estimation was 0.28 CHF which accounts for 47.52% surprise. Company revenue for the same period amounts to 585.30 M CHF despite the estimated figure of 588.02 M CHF. Estimated earnings per share for the next quarter are 0.31 CHF, and revenue is expected to reach 601.11 M CHF. Also watch annual changes over time to get a bigger picture of BM8 earnings per share and revenue dynamics.